When I mention lupus to my patients, sometimes I get a confused look because it is not a well-understood condition. People wonder why the body would attack itself, as is the case with lupus and other autoimmune diseases. Here are five surprising facts that many people do not know about lupus.
ImmuPharma PLC (LON: IMM), the specialist drug discovery and development company, is pleased to announce that it has, with immediate effect, appointed Stanford Capital Partners and SI Capital as joint brokers. They will work in conjunction with Northland Capital Partners who are the Company’s NOMAD and broker.